Minerva Neurosciences, Inc. (NERV) vs NervGen Pharma Corp. Common stock (NGEN)
A side-by-side comparison of Minerva Neurosciences, Inc. and NervGen Pharma Corp. Common stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NERV
Minerva Neurosciences, Inc.
$3.42HealthcareDelayed quote: Oct 6, 2026, 11:55 AM EDT
NGEN
NervGen Pharma Corp. Common stock
$1.81HealthcareDelayed quote: Oct 6, 2026, 11:54 AM EDT
Total return — NERV vs NGEN
growth of $100 · dividends reinvested · last 1yNERV -13.5% (-13.5%/yr)NGEN -57.6% (-57.6%/yr)NERV compounded faster over this window
NERV NGEN
NERV vs NGEN: by the numbers
- •NERV is the larger company ($159M vs $149M market cap).
Metrics side by side
Valuation
| Metric | NERV | NGEN |
|---|---|---|
| P/B ratio | N/A | 12.21 |
Profitability
| Metric | NERV | NGEN |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | N/A | -397.38% |
| ROIC | -38.56% | -223.90% |
Growth (annualized)
| Metric | NERV | NGEN |
|---|---|---|
| Total return CAGR (5Y) | -22.14% | N/A |
Go deeper
Dig into the metrics
Minerva Neurosciences ROENervGen Pharma Corp. Common stock ROEMinerva Neurosciences operating marginNervGen Pharma Corp. Common stock operating marginMinerva Neurosciences revenue growthNervGen Pharma Corp. Common stock revenue growthMinerva Neurosciences free cash flowNervGen Pharma Corp. Common stock free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.